Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1513583

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1513583

Methane Sulfonic Acid Market Size By Product Type (Industrial grade, Pharmaceutical grade), Application (Electroplating, Pharmaceuticals, Chemical Synthesis, Industrial Cleaning) & Forecast, 2024 - 2032

PUBLISHED:
PAGES: 300 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

Methane sulfonic acid market is estimated to register over 4.8% CAGR between 2024 and 2032 driven by the rising demand in the pharmaceuticals sector to cater to uses as catalysts and reagents in the synthesis of active pharmaceutical ingredients (APIs) and other pharmaceutical compounds. For instance, in October 2023, Clariant launched a new range of excipients to improve the stability and solubility of APIs. The strong acidity, lack of volatility, and solubility in organic solvents makes methane sulfonic acid (MSA) superior to conventional acids, such as sulfuric acid.

The increasing adoption in eco-friendly and sustainable processes will also influence the market growth. As industries globally move towards greener practices, the biodegradability and less corrosive nature of MSA compared to conventional acids makes it an ideal alternative in various applications. In the pharmaceutical industry, the acid is used as a catalyst in esterification and polymerization reactions for promoting more efficient and sustainable manufacturing processes. The rise in R&D activities aimed at discovering new applications and improving the production processes will stimulate the market growth.

The MSA industry is classified into product type, application and region.

Based on product type, the market size from the pharmaceutical grade segment is anticipated to witness substantial growth through 2032 due to its critical role in the synthesis of APIs and other pharmaceutical intermediates. The strong acidic properties and excellent solubility in organic solvents makes this MSA an ideal catalyst and reagent for various reactions in drug manufacturing. As the pharmaceutical industry continues to expand, driven by increasing healthcare demands and the development of new medications, the need for high-purity MSA in drug synthesis processes will rise.

Methane sulfonic acid industry from the chemical synthesis segment will generate notable revenue during 2024-2032 owing to its efficacy as a catalyst in a wide range of organic reactions. With its strong acidity, non-oxidizing nature, and high solubility in organic solvents, MSA isa preferred catalyst for esterification, alkylation, and polymerization processes. The ability to facilitate more efficient and cleaner chemical reactions compared to traditional acids for decreasing by-product formation and improving the overall yield and process sustainability will add to the segment growth.

North America methane sulfonic acid industry is slated to witness a significant growth rate through 2032, attributed to the industrial base and stringent environmental regulations. The automotive and electronics sectors are extensively using MSA in electroplating and surface treatment processes to enhance product durability and performance. The regulatory emphasis on reducing hazardous emissions and promoting sustainable industrial practices over more traditional and corrosive acids will stimulate the regional market growth.

Product Code: 9104

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Key manufacturers
    • 3.1.2 Distributors
    • 3.1.3 Profit margins across the industry
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing demand from pharmaceutical industry
      • 3.2.1.2 Rising adoption in electronics manufacturing
      • 3.2.1.3 Growing popularity as a catalyst and intermediate in chemical synthesis
    • 3.2.2 Market challenges
      • 3.2.2.1 Volatility in raw material prices
      • 3.2.2.2 Stringent regulations regarding handling and disposal
    • 3.2.3 Market opportunity
      • 3.2.3.1 New opportunities
      • 3.2.3.2 Growth potential analysis
  • 3.3 Raw material landscape
    • 3.3.1 Manufacturing trends
    • 3.3.2 Technology evolution
      • 3.3.2.1 Sustainable manufacturing
        • 3.3.2.1.1 Green practices
        • 3.3.2.1.2 Decarbonization
    • 3.3.3 Sustainability in raw materials
    • 3.3.4 Raw material pricing trends (USD/Ton)
      • 3.3.4.1 U.S.
      • 3.3.4.2 European Union
      • 3.3.4.3 UK
      • 3.3.4.4 China
      • 3.3.4.5 Southeast Asia
      • 3.3.4.6 GCC
  • 3.4 Regulations & market impact
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Company market share analysis
  • 4.2 Competitive positioning matrix
  • 4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Product Type, 2021-2032 (USD Million, Kilo Tons)

  • 5.1 Key trends
  • 5.2 Industrial grade
  • 5.3 Pharmaceutical grade

Chapter 6 Market Size and Forecast, By Application, 2021-2032 (USD Million, Kilo Tons)

  • 6.1 Key trends
  • 6.2 Electroplating
  • 6.3 Pharmaceuticals
  • 6.4 Chemical synthesis
  • 6.5 Industrial cleaning
  • 6.6 Others

Chapter 7 Market Size and Forecast, By Region, 2021-2032 (USD Million, Kilo Tons)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 South Korea
    • 7.4.5 Australia
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 MEA
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 South Africa
    • 7.6.4 Rest of MEA

Chapter 8 Company Profiles

  • 8.1 Arkema
  • 8.2 Ataman Chemicals
  • 8.3 BASF
  • 8.4 BLDpharm
  • 8.5 CDH Fine Chemicals
  • 8.6 Finar Chemicals
  • 8.7 Glentham Life Sciences
  • 8.8 Haihang Industry Co., Ltd.
  • 8.9 Hebei Yanuo Bioscience Co Ltd
  • 8.10 Hydrite Chemical Co.
  • 8.11 Richman Chemical
  • 8.12 SIPCAM OXON
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!